-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
POINT Biopharma Global Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q3 2020 to Q3 2023.
- POINT Biopharma Global Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2023 was 106M shares, a 14.5% increase year-over-year.
- POINT Biopharma Global Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 96M shares, a 30% increase from 2021.
- POINT Biopharma Global Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 73.9M shares, a 90% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)